Author： Sylvester Christin
Publisher： Informa Healthcare
ISSN： 0882-0538
Source： Seminars in Ophthalmology, Vol.23, Iss.5-6, 2008-09, pp. : 318-323
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Retinopathy of prematurity (ROP) is a rapidly evolving area of pediatric ophthalmology. Over the past decade, a new understanding of the pathophysiology of ROP has emerged. Advances in clinical research have lead to modifications in screening criteria and treatment guidelines for ROP. With this knowledge, new treatment modalities such as anti-angiogenic agents are being investigated. This review will highlight some of the current concepts related to ROP.
Related content
Emerging Treatments for Retinopathy of Prematurity
By Mantagos Iason Vanderveen Deborah Smith Lois
Seminars in Ophthalmology, Vol. 24, Iss. 2, 2009-03 ,pp. :
Access to resources
Recommend
Risk Factors in Retinopathy of Prematurity
Ophthalmologica, Vol. 214, Iss. 2, 2000-03 ,pp. :
Retinopathy of Prematurity: Clinic and Pathogenesis
Ophthalmologica, Vol. 222, Iss. 4, 2008-05 ,pp. :
Risk Factors for Acute Retinopathy of Prematurity
Annals of Ophthalmology, Vol. 39, Iss. 2, 2007-06 ,pp. :